These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17325287)

  • 21. ALS trial design: expectation and reality.
    Miller RG; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():52-4. PubMed ID: 15512873
    [No Abstract]   [Full Text] [Related]  

  • 22. ALSFRS-R.
    Gordon PH; Miller RG; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():90-3. PubMed ID: 15512883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not gold.
    Armon C; Guiloff RJ; Bedlack R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):109-12. PubMed ID: 12495570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy development for ALS: lessons learned and path forward.
    Lanka V; Cudkowicz M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):131-40. PubMed ID: 18574756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is next in ALS clinical trials?
    Sorenson EJ
    Neurology; 2007 Aug; 69(8):719-20. PubMed ID: 17709702
    [No Abstract]   [Full Text] [Related]  

  • 26. [Etiological drug therapy for amyotrophic lateral sclerosis].
    Cintas P
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALS endpoints. Survival.
    Cedarbaum J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():79-83. PubMed ID: 15512880
    [No Abstract]   [Full Text] [Related]  

  • 28. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What has changed with riluzole?
    Meininger V; Lacomblez L; Salachas F
    J Neurol; 2000 Dec; 247 Suppl 6():VI/19-22. PubMed ID: 19714404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
    Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A
    Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy, lithium, and amyotrophic lateral sclerosis.
    Pasquali L; Longone P; Isidoro C; Ruggieri S; Paparelli A; Fornai F
    Muscle Nerve; 2009 Aug; 40(2):173-94. PubMed ID: 19609902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALS combination treatment. Drug cocktails.
    Rosenfeld J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():115-7. PubMed ID: 15512890
    [No Abstract]   [Full Text] [Related]  

  • 34. Riluzole.
    Gelinas DF
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():3-4. PubMed ID: 11466957
    [No Abstract]   [Full Text] [Related]  

  • 35. ALSUntangled No. 8: Low dose naltrexone for ALS.
    ALSUntangled Group
    Amyotroph Lateral Scler; 2011 Jan; 12(1):76-8. PubMed ID: 21174518
    [No Abstract]   [Full Text] [Related]  

  • 36. The biopharmaceutical industry and new drugs for amyotrophic lateral sclerosis.
    Malta E
    Adv Neurol; 1995; 68():263-9; discussion 271-5. PubMed ID: 8787239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of amyotrophic lateral sclerosis - what is the next step?
    Ludolph AC
    J Neurol; 2000 Dec; 247 Suppl 6():VI/13-8. PubMed ID: 19714403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. North East ALS Study Group.
    Cudkowicz M; Shefner J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():125-7. PubMed ID: 15512893
    [No Abstract]   [Full Text] [Related]  

  • 39. Multi-drug therapy in amyotrophic lateral sclerosis: the case for a multi-drug approach.
    Rosenfeld J
    Muscle Nerve; 2004 Nov; 30(5):673-5. PubMed ID: 15452840
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulatory issues in ALS clinical trials.
    Bryan WW
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():36-41. PubMed ID: 15512868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.